NEW YORK (
) -- These four companies reached 52-week highs on Tuesday:
Thomas & Betts
( TNB) and
Each of these stocks received a buy rating from
The apparel and sneaker company was upgraded on Tuesday to a
by Argus. The analysts' price target is $118.
Sterne Agee analysts wrote in a report on Jan. 20 that they think the introduction of the new Nike+ FuelBand "is one more step in Nike's strategy to connect with consumers and grow market share."
Shares of Nike hit a 52-week high on Tuesday of $104.94. The stock's 52-week low of $69.43 was set on March 22.
gives Nike an A+ grade with a
price target. The stock has risen 8.78% year to date.
Steve Madden, the fashion footwear company, is scheduled to report fourth-quarter earnings on Feb. 20. Analysts, on average, anticipate earnings of 56 cents a share on revenue of $266.20 million.
"We believe that the mild winter benefited SHOO by shifting customerdollars from warm and comfort boots to fashion footwear," Sterne Agee analysts wrote in a report on Jan. 23. "Strong junior business has been called out by various department stores and footwear retailers."
Shares of Steve Madden hit a 52-week high of $41.86 on Tuesday. The stock's 52-week low of $26.05 was reached on Feb. 2.
Steve Madden receives an A- grade from
price target. The stock increased 19.22% year to date.
Thomas & Betts
The electrical components manufacturer reached a deal Monday to be acquired by Switzerland's
for about $3.9 billion, or $72 a share, in cash.
"The $3.9 billion acquisition represents about a ~24% premium to TNB's closing enterprise value as of Friday January 27, 2012 when the stock closed at $57.95," KeyBanc Capital Markets analysts wrote in a report Tuesday. "TNB also reported better than expected 4Q11 earnings ($1.00 operating EPS vs. KBCM: $0.92 and First Call $0.88), which was in line with our positive view on the shares as noted in our Industrial Preview note on January 19, 2012."
Shares of Thomas & Betts hit a 52-week high on Tuesday of $71.47. The stock's 52-week low of $37.51 was reached on Oct. 4.
gives Thomas & Betts an A- grade with a
price target. The stock has risen 30.81% year to date.
Cantor Fitzgerald analysts raised their price target on the health care company on Jan. 18 to $51 from $47.50.
"We believe that Centene is among the best positioned of the Medicaid managed care companies to capitalize on the growing role of managed care in state Medicaid programs," Cantor Fitzgerald analysts wrote in a report. "It recently entered Kentucky, will enter Louisiana in February, and will expand in Texas beginning in March. Longer-term, we believe that the company is also well positioned for major reprocurements and expansions in Florida, Georgia, and Illinois."
Shares of Centene hit a 52-week high of $45.45 on Tuesday. The stock's 52-week low of $25.28 was reached on Oct. 4.
Centene gets an A- grade from
price target. The stock increased 13.19% year to date.
-- Written by Alexandra Zendrian
>To contact the writer of this article, click here:
>To submit a news tip, send an email to:
>To follow the writer on Twitter, go to